1 |
Anaya-Ruiz M, Vallejo-Ruiz V, Flores-Mendoza L, Perez-Santos M (2014). Female breast cancer incidence and mortality in Mexico, 2000-2010. Asian Pac J Cancer Prev, 15, 1477-9.
DOI
|
2 |
Antunes A, Fierro IM, Di Sabato R, Rohem dos Santos P, Lins Mendes FM (2013). R&D landscape for breast cancer through patent documents. J Cancer Ther, 4, 56.
|
3 |
Dogan N, Toprak D (2014). Female breast cancer mortality rates in Turkey. Asian Pac J Cancer Prev, 15, 7569-7573.
DOI
|
4 |
Donato HM, De Oliveira CF (2006). Breast pathology: evaluation of the Portuguese scientific activity based on bibliometric indicators. Acta Medica Portuguesa, 19, 225-34.
|
5 |
Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancerbase No. 11. Lyon, France: international agency for research on cancer. Last accessed October. 2014.
|
6 |
Canongia C (2007). Synergy between competitive intelligence (CI), knowledge management (KM) and technological foresight (TF) as a strategic model of prospecting-the use of biotechnology in the development of drugs against breast cancer. Biotechnology Advances, 25, 57-74.
DOI
|
7 |
Ha R, Chow D, Wynn R, (2014). Global trend in breast cancer imaging research 1992-2012: bibliometry study. AJR Am J Roentgenol, 202, 696-7.
DOI
|
8 |
Hong W, Dong E (2014). The past, present and future of breast cancer research in China. Cancer Lett, 351, 1-5.
DOI
|
9 |
Ibraheem D, Elaissari A, Fessi H (2014). Gene therapy and DNA delivery systems. Int J Pharm, 459, 70-83.
DOI
ScienceOn
|
10 |
Kotepui M, Wannaiampikul S, Chupeerach C, Duangmano S, (2014). A bibliometric analysis of diets and breast cancer research. Asian Pac J Cancer Prev, 15, 7625-8.
DOI
|
11 |
Majeed W, Aslam B, Javed I, et al (2014). Breast cancer: major risk factors and recent developments in treatment. Asian Pac J Cancer Prev, 15, 3353-8.
DOI
|
12 |
Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E (2014). European cancer mortality predictions for the year 2014. Ann Oncol, 25, 1650-6.
DOI
|
13 |
McCrudden CM, McCarthy HO (2014). Current status of gene therapy for breast cancer: progress and challenges. Appl Clin Genet, 7, 209-220.
|
14 |
Moghimi M, Fathi M, Marashi A, et al (2013). A scientometric analysis of 20 years of research on breast reconstruction surgery: a guide for research design and journal selection. Arch Plast Surg, 40, 109-15.
DOI
|
15 |
Perez-Santos JLM, Anaya-Ruiz M (2013). Mexican breast cancer research output, 2003-2012. Asian Pac J Cancer Prev., 14, 5921-23.
DOI
ScienceOn
|
16 |
Petrocca F, Lieberman J (2014). Promise and challenge of RNA interference-based therapy for cancer. J Clin Oncol, 29, 747-54.
|
17 |
Shahkhodabandeh S, Piri Z, Biglo MH, et al (2009). Breast cancer in Iran: iranian scientists approach to breast cancer researchers in medline database. Iranian Quarterly J Breast Disease, 2, 49-59.
|
18 |
Shi XJ, Au WW, Wu KS, Chen LX, Lin K (2014). Mortality characteristics and prediction of female breast cancer in China from 1991 to 2011. Asian Pac J Cancer Prev, 15, 2785-91.
DOI
ScienceOn
|
19 |
Youlden DR, Cramb SM, Yip CH, Baade PD (2014). Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med. 11, 101-15.
|
20 |
Walther W, Schlag PM (2014), Current status of gene therapy for cancer. Curr Opin Oncol, 25, 659-64.
|